- |||||||||| Trial completion, Trial completion date: EPGP: Epilepsy Phenome/Genome Project (clinicaltrials.gov) - Nov 13, 2018
P=N/A, N=4150, Completed, Active, not recruiting --> Completed | Trial completion date: Apr 2014 --> Oct 2018
- |||||||||| vigabatrin / Generic mfg.
Trial completion, Enrollment change: Sabril Patient Registry (clinicaltrials.gov) - Jul 30, 2016 P=N/A, N=9423, Completed, Recruiting --> Completed | N=10 --> 8 Enrolling by invitation --> Completed | N=15000 --> 9423
- |||||||||| Enrollment change: EPGP: Epilepsy Phenome/Genome Project (clinicaltrials.gov) - Jan 14, 2014
P=N/A, N=4150, Active, not recruiting, Trial primary completion date: Jul 2015 --> Jul 2016 N=5250 --> 4150
- |||||||||| Enrollment closed: EPGP: Epilepsy Phenome/Genome Project (clinicaltrials.gov) - Dec 12, 2012
P=N/A, N=4150, Active, not recruiting, Recruiting --> Completed Recruiting --> Active, not recruiting
|